Benzinga | May 18, 2021 08:01AM EDT

JonesTrading Initiates Coverage On aTyr Pharma with Buy Rating, Announces Price Target of $15

JonesTrading analyst Prakhar Agrawal initiates coverage on aTyr Pharma (NASDAQ:LIFE) with a Buy rating and announces Price Target of $15.